Showing 5111-5120 of 5644 results for "".
- Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma to Advance Its Dry Eye Programhttps://modernod.com/news/aerie-pharmaceuticals-announces-agreement-to-acquire-avizorex-pharma-to-advance-its-dry-eye-program/2477097/Aerie Pharmaceuticals announced it is acquiring Avizorex Pharma, a Spanish ophthalmic pharmaceutical company developing therapeutics for the treatment of dry eye disease. AVX completed a phase 2a study in dry eye subjects earlier this year with its lead product candidate, AVX-012. The acti
- Katena Announces the Acquisition of Micro Medical Instrumentshttps://modernod.com/news/katena-announces-the-acquisition-of-micro-medical-instruments/2477093/Katena Products announced the purchase of Micro Medical Instruments (MMI), a medical contract manufacturing service. Terms of the deal were not disclosed. “The acquisition of MMI, Inc. will strengthen Katena’s manufacturing capability,” Mark Fletcher, CEO of Katena Products, said i
- Understanding the Eye’s ‘Plumbing’ Could Lead to Future Treatments for Glaucoma, Other Diseaseshttps://modernod.com/news/understanding-the-eyes-plumbing-could-lead-to-future-treatments-for-glaucoma-other-diseases/2477092/Scientists in the University of Arizona Department of Physiology have identified a potential molecular mechanism that may hold the key to understanding how pressure is regulated in the eye. Funded by a $2.3 million 5-year grant from the National Institutes of Health (NIH) National Eye Inst
- Ocular Therapeutix Announces Strategic Update and Operational Restructuringhttps://modernod.com/news/ocular-therapeutix-announces-strategic-update-and-operational-restructuring/2477081/Ocular Therapeutix announced an operational restructuring plan that the company says is expected to result in an estimated $11 million in annualized savings through personnel reductions and approximately $14 million in one-time program deferrals. The company estimates that it will record costs as
- Optina Diagnostics and Wagner Macula Retina Center to Conduct a Study to Identify the Causes of Memory Loss Through Eye Diagnosticshttps://modernod.com/news/optina-diagnostics-and-wagner-macula-retina-center-will-collaborate-to-conduct-a-clinical-study-to-identify-the-causes-of-memory-loss-through-eye-diagnostics/2477076/Optina Diagnostics and Wagner Macula Retina Center are entering into a collaboration agreement to conduct a clinical study for the advancement of Optina’s Retinal Deep Phenotyping platform. This collaboration will lay the groundwork for Optina’s future pivotal clinical trial. &
- AGTC Announces Stargardt Disease as its Second Preclinical Ophthalmology Programhttps://modernod.com/news/agtc-announces-stargardt-disease-as-its-second-preclinical-ophthalmology-program/2477071/Applied Genetic Technologies Corporation (AGTC), announced that it has identified Stargardt disease as the second ophthalmology program in its previously announced preclinical pipeline expansion, which also includes a program targeting the dry form of age-related macular degenerat
- Aerie Pharmaceuticals Announces Positive Topline Results for Netarsudil in Phase 2 Study Conducted in Japanhttps://modernod.com/news/aerie-pharmaceuticals-announces-positive-topline-results-for-netarsudil-in-phase-2-study-conducted-in-japan/2477069/Aerie Pharmaceuticals reported positive topline results for the company’s phase 2 clinical trial evaluating netarsudil ophthalmic solution in Japanese patients. Netarsudil is a Rho kinase (ROCK) inhibitor specifically designed to increase outflow of aqueous humor through the trabecular meshwork,
- Allergan Issues Recall for Certain Lots of Xen 45https://modernod.com/news/allergan-issues-recall-for-certain-lots-of-xen-45/2477061/Allergan has initiated a voluntary recall of its XEN 45 glaucoma drainage device after a small number of units in an unreleased lot were observed to have trace amounts of polishing compounds that are used in the needle sleeve manufacturing process, according to a joint news release with ASCRS.
- Johnson & Johnson Vision Launches Tecnis Eyhance Monofocal IOL in Indiahttps://modernod.com/news/johnson-johnson-vision-launches-tecnis-eyhance-monofocal-iol-in-india/2477059/Johnson & Johnson Vision announced the launch of Tecnis Eyhance IOL, which is designed to extend depth of focus from distance to intermediate vision. Over the past several decades, India’s eye care system has made tremendous strides towards high q
- EyePrint Prosthetics Releases New Scleral Lens Technology: ScanFitPROhttps://modernod.com/news/eyeprint-prosthetics-releases-new-scleral-lens-technology-scanfitpro/2477058/EyePrint Prosthetics has announced the development of its new scleral lens fitting software, ScanFitPRO. This new technology simplifies every-day contact lens fitting by employing EyePrint Prosthetic’s scleral lens designer algorithm to automatically design a lens in 3-dimensional space, accordin